Preclinical and Clinical Testing
TetraQ provides contract preclinical and clinical testing services to biopharmaceutical companies that are engaged in the business of developing new pharmaceuticals for human use and who are seeking assistance with selecting or confirming a drug candidate - see Roadmap.
TetraQ is GLP-recognized for its bioanalytical and toxicology services thereby ensuring that the data generated will be accepted for review by the international regulatory agencies such as the FDA, EMA and TGA.
TetraQ regularly provides GLP bioanalytical services to support preclinical studies as well as early phase clinical trials and bioequivalence studies in humans.
TetraQ has a track record in trouble-shooting difficulties in developing bioanalytical methods to detect and measure compounds and has an extensive library of fully validated bioanalytical methods on file.
Preclinical and Clinical studies vary widely in complexity, costs, duration and importance. Careful planning in the early stages of a project can minimise costs and maximise results. TetraQ can assist to optimize preclinical and clinical drug development plans.